Drug
Gadolinium ethoxybenzyl DTPA clinical trials
Also written Eovist, Gadoxetate disodium and ZK 139834.
A product of Gadolinium DTPA; its studies count on that page too.
- studies test it
- 13
- open now
- 1
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the gadolinium ethoxybenzyl DTPA studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 6
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 9
Bayer (3) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Duke University (1) · Sara Varea (1) · University of Southern California (1) · Guerbet (1) · University of Colorado, Denver (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gadolinium ethoxybenzyl DTPA is read from its arms, and is right about nine times in ten.
Testing it · 13
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as Gadoxetate disodium
- Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedPhase 4University of Colorado, DenverNCT04973007Written as Gadoxetate disodium
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsActive, not recruitingNot applicableM.D. Anderson Cancer CenterNCT02156739Written as Gadoxetate Disodium
- Improving CBCT for Liver IG-SBRT Using Gadoxetate DisodiumWithdrawnPhase 4Slawa CwajnaNCT03215355Written as Primovist
- Gadoxetate Enhanced Imaging Study to Detect Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT01867424Written as Eovist
- Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerStatus unknownEarly Phase 1University of CincinnatiNCT03960788Written as Gadoxetate Sodium
- Eovist vs. Dotarem Healthy Volunteer MRICompletedPhase 4Duke UniversityNCT02431598Written as gadoxetate disodium
- Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast AgentTerminatedPhase 3BayerNCT02084628Written as Gadoxetate disodium (Eovist/Primovist, BAY86-4873)
- Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive DiagnosisCompletedPhase 4Sara VareaNCT01575574Written as GADOXETIC ACID
- MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedPhase 1University of Southern CaliforniaNCT02578602Written as Gadoxetate Disodium
- 24hr Imaging Of HCC After EOVISTWithdrawnEarly Phase 1Massachusetts General HospitalNCT01968629Written as Eovist
- Primovist / Eovist in Renally Impaired PatientsCompletedPhase 4BayerNCT00908596Written as Gadoxetic acid disodium (Primovist, BAY86-4873)
- Efficacy and Safety of Primovist in Chinese PatientsCompletedPhase 3BayerNCT00526188Written as Gadoxetic Acid Disodium (Primovist, BAY86-4873)
Codes
What other systems call gadolinium ethoxybenzyl DTPA · ClinicalTrials.gg INT003622
- MeSH (NLM) C073590gadolinium ethoxybenzyl DTPAConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3QJA87N40SGADOXETIC ACIDConfirmed FDA, NLM
- RxNorm 802624One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C073590 | gadolinium ethoxybenzyl DTPA | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3QJA87N40S | GADOXETIC ACID | Confirmed FDA, NLM |
| RxNorm | 802624 | — | One source FDA |
Also registered as gadoxetate disodium (UNII HOY74VZE0M · RxNorm 637320).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.